EE03689B1 - Antibakteriaalsed karbapeneemühendid, neid sisaldavad kompositsioonid ja nende kasutamine - Google Patents

Antibakteriaalsed karbapeneemühendid, neid sisaldavad kompositsioonid ja nende kasutamine

Info

Publication number
EE03689B1
EE03689B1 EE9800355A EE9800355A EE03689B1 EE 03689 B1 EE03689 B1 EE 03689B1 EE 9800355 A EE9800355 A EE 9800355A EE 9800355 A EE9800355 A EE 9800355A EE 03689 B1 EE03689 B1 EE 03689B1
Authority
EE
Estonia
Prior art keywords
compositions containing
carbapenem compounds
antibacterial
antibacterial carbapenem
compounds
Prior art date
Application number
EE9800355A
Other languages
English (en)
Estonian (et)
Other versions
EE9800355A (et
Inventor
R. Wilkening Robert
W. Ratcliffe Ronald
A. Blizzard Timothy
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609741.5A external-priority patent/GB9609741D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of EE9800355A publication Critical patent/EE9800355A/xx
Publication of EE03689B1 publication Critical patent/EE03689B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EE9800355A 1996-04-24 1997-04-21 Antibakteriaalsed karbapeneemühendid, neid sisaldavad kompositsioonid ja nende kasutamine EE03689B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1618496P 1996-04-24 1996-04-24
GBGB9609741.5A GB9609741D0 (en) 1996-05-10 1996-05-10 Carbapenem antibacterial compounds compositions containing such componds and methods of treatment
PCT/US1997/006626 WO1997040048A1 (en) 1996-04-24 1997-04-21 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Publications (2)

Publication Number Publication Date
EE9800355A EE9800355A (et) 1999-04-15
EE03689B1 true EE03689B1 (et) 2002-04-15

Family

ID=26309297

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800355A EE03689B1 (et) 1996-04-24 1997-04-21 Antibakteriaalsed karbapeneemühendid, neid sisaldavad kompositsioonid ja nende kasutamine

Country Status (30)

Country Link
EP (1) EP0906313B1 (cs)
JP (1) JP3176068B2 (cs)
KR (1) KR20000010599A (cs)
CN (1) CN1074767C (cs)
AR (1) AR006810A1 (cs)
AT (1) ATE260915T1 (cs)
AU (1) AU707459B2 (cs)
BG (1) BG102949A (cs)
BR (1) BR9708864A (cs)
CA (1) CA2252402C (cs)
CO (1) CO4990968A1 (cs)
CZ (1) CZ340798A3 (cs)
DE (1) DE69727931T2 (cs)
EA (1) EA001296B1 (cs)
EE (1) EE03689B1 (cs)
ES (1) ES2216142T3 (cs)
HR (1) HRP970213A2 (cs)
HU (1) HUP9901778A3 (cs)
ID (1) ID16662A (cs)
IL (1) IL126480A0 (cs)
IS (1) IS4861A (cs)
NO (1) NO984949L (cs)
NZ (1) NZ332183A (cs)
PE (1) PE64298A1 (cs)
PL (1) PL186881B1 (cs)
SK (1) SK283550B6 (cs)
TR (1) TR199802140T2 (cs)
TW (1) TW539677B (cs)
WO (1) WO1997040048A1 (cs)
YU (1) YU46298A (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406457B1 (en) 1994-03-02 2002-06-18 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
US7163522B1 (en) 1994-03-02 2007-01-16 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
WO1998051677A1 (en) * 1997-05-13 1998-11-19 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
US5908936A (en) * 1997-05-13 1999-06-01 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
ATE238305T1 (de) * 1997-10-23 2003-05-15 Merck & Co Inc Antibakterielle carbapenem-verbindungen, zusammensetzungen, die diese verbindungen enthalten und behandlungsmethoden
AU739799B2 (en) * 1997-10-23 2001-10-18 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions and methods of treatment
US6140318A (en) * 1997-10-23 2000-10-31 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6271222B1 (en) * 1998-05-28 2001-08-07 Merck & Co., Inc. Penem antibacterial compounds, compositions and methods of treatment
JP2002518402A (ja) * 1998-06-17 2002-06-25 メルク エンド カムパニー インコーポレーテッド カルバペネム中間体の合成方法、及び製造された化合物
AU4710999A (en) * 1998-06-25 2000-01-10 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
CA2335571A1 (en) * 1998-06-25 1999-12-29 Merck & Co. Inc. (heterocyclic) methyl substituted carbapenem antibacterials
US7672747B2 (en) 2000-03-30 2010-03-02 Lam Research Corporation Recipe-and-component control module and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
US5451579A (en) * 1994-02-15 1995-09-19 Merck & Co., Inc. 1-β-methyl-carbapenem, compositions containing same and methods of use

Also Published As

Publication number Publication date
HK1021186A1 (en) 2000-06-02
NZ332183A (en) 2000-05-26
BR9708864A (pt) 1999-08-03
CA2252402C (en) 2002-12-24
EA199800949A1 (ru) 1999-04-29
TW539677B (en) 2003-07-01
IL126480A0 (en) 1999-08-17
BG102949A (bg) 1999-10-29
NO984949D0 (no) 1998-10-23
ID16662A (id) 1997-10-30
CO4990968A1 (es) 2000-12-26
HUP9901778A3 (en) 2000-06-28
AU2462997A (en) 1997-11-12
HRP970213A2 (en) 1998-06-30
WO1997040048A1 (en) 1997-10-30
AR006810A1 (es) 1999-09-29
SK145498A3 (en) 1999-10-08
CN1074767C (zh) 2001-11-14
JP3176068B2 (ja) 2001-06-11
EA001296B1 (ru) 2000-12-25
PL329376A1 (en) 1999-03-29
CN1222912A (zh) 1999-07-14
SK283550B6 (sk) 2003-09-11
KR20000010599A (ko) 2000-02-15
CZ340798A3 (cs) 1999-03-17
DE69727931D1 (de) 2004-04-08
DE69727931T2 (de) 2005-04-14
NO984949L (no) 1998-12-21
TR199802140T2 (xx) 1999-01-18
JPH11508279A (ja) 1999-07-21
EP0906313A1 (en) 1999-04-07
YU46298A (sh) 2000-03-21
EE9800355A (et) 1999-04-15
CA2252402A1 (en) 1997-10-30
EP0906313B1 (en) 2004-03-03
HUP9901778A2 (hu) 1999-09-28
PL186881B1 (pl) 2004-03-31
IS4861A (is) 1998-10-06
PE64298A1 (es) 1998-10-30
ES2216142T3 (es) 2004-10-16
AU707459B2 (en) 1999-07-08
ATE260915T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
EE9800028A (et) Iprotroopiumsoolad, neid sisaldavad ravimkompositsioonid ja nende kasutamine
FI971516L (fi) Antimikrobinen koostumus
FI945281L (fi) Heterosykliset yhdisteet, niiden valmistus ja käyttö
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
BR9707609A (pt) Composição para desinfecção
DE69520639D1 (de) Desinfizierende Zusammensetzung
FI961219L (fi) Kemialliset yhdisteet, niiden valmistus ja käyttö
FI931901A7 (fi) Atsoliyhdisteet, niiden valmistus ja käyttö
EE200000621A (et) Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine
FI951966L (fi) Uudet polyeeniyhdisteet, niitä sisältävät farmaseuttiset ja kosmeettiset koostumukset ja niiden käyttö
FI972090A7 (fi) Antibakteeriset dibentsimidatsolijohdannaiset
DE69827744D1 (de) Polybuten-1 enthaltende polyolefinzusammensetzung
FI944417A7 (fi) Atsoliyhdisteet, niiden valmistus ja käyttö
FI951967L (fi) Uudet kaksirenkaiset aromaattiset yhdisteet, niitä sisältävät farmaseuttiset ja kosmeettiset koostumukset ja niiden käyttö
EE03689B1 (et) Antibakteriaalsed karbapeneemühendid, neid sisaldavad kompositsioonid ja nende kasutamine
NO990463D0 (no) Azabicykliske karbamoyloksymutilinderivater for antibakteriell anvendelse
DE69313783D1 (de) Vernetzende zusammensetzung
FI970997A7 (fi) Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö
ID17561A (id) Komposisi untuk pemakaian luar
EE03690B1 (et) Imidasopüridasiinid, neid sisaldav ravim ja nendekasutamine
FI954229L (fi) Heterosykliset yhdisteet, niiden käyttö ja valmistus
FI964899A7 (fi) Uusia taksoideja, niiden valmistus ja niitä sisältäviä koostumuksia
DE69605988D1 (de) Synergistische antimikrobielle Zusammensetzung
FI20012140A7 (fi) Uudet kvaternääriset yhdisteet, niitä sisältävät koostumukset ja niiden käyttöjä
BR9503633A (pt) Composição desinfetante

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

MM4A Lapsed by not paying the annual fees

Effective date: 20040421